Study designs of evaluations included in the review
Randomised controlled trials (RCTs) were included.
Specific interventions included in the review
Various antifungal agents possessing either systemic or topical antifungal properties (miconazole, amphotericin, ketoconazole, clotrimazole, fluconazole) versus placebo.
Participants included in the review
Non-AIDS immunocompromised cancer patients, not selected according to their fungal colonisation status. Data concerning children were not included in this review.
Outcomes assessed in the review
Occurrence of oropharyngeal candidiasis and eventual oropharyngeal colonisation status with yeasts.
How were decisions on the relevance of primary studies made?
The authors do not state how the papers were selected for the review, or how many of the authors performed the selection.